TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 2 | 1 | 3 | -0 | 0 | -1 | 0 | -3 | 8 | 1 |
P | %wins | 67 | 67 | 33 | 67 | 33 | 67 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/29/18 14:30 | 6/27/18 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tilton Glenn F | IL | D | P | 496 | 91.90 | 0 | 5 | 16 | 40 | D | |||||||||||||||
5/8/14 17:33 | 5/6/14 | PSX | Phillips 66 | DE | Energy | OilRef | Petroleum Refining | Tilton Glenn F | TX | D | P | 498 | 84.41 | 33 | 6 | 63 | 15 | D | 181 | 35 | 33 | 21 | 10 | 5 | 1 | 2 | -1 | 1 | 2 | 0 | -9 | -1 | |
2/27/09 19:34 | 2/25/09 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Tilton Glenn F | D | P | 107 | 53.63 | 33 | 2 | 22 | 11 | B | 0 | -2 | -1 | -5 | -1 | 17 | ||||||||||
9/19/07 21:48 | 9/18/07 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Tilton Glenn F | D | P | 230 | 52.49 | 33 | 4 | 457 | 5 | I | 29 | 11 | 0 | -1 | -1 | 6 | 3 | 3 | 0 | 1 | -5 | 6 | 2 | 9 | ||
11/23/05 15:21 | 11/22/05 | TXU | Txu Corp /tx/ | TX | Utility | ElcPwr | Electric Services | Tilton Glenn F | TX | D | P | 50 | 99.74 | 0 | 1 | 91 | 1 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |